AXA SA (OTCMKTS:AXAHY – Get Rating) was the target of a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 19,100 shares, an increase of 29.1% from the March 15th total of 14,800 shares. Based on an average daily volume of 238,000 shares, the short-interest ratio is currently 0.1 days.
A number of equities research analysts have issued reports on the company. The Goldman Sachs Group initiated coverage on AXA in a research report on Tuesday, February 15th. They set a “buy” rating for the company. Morgan Stanley cut their price target on AXA from €35.00 ($38.04) to €32.00 ($34.78) and set an “overweight” rating on the stock in a research note on Tuesday, April 5th. Zacks Investment Research cut AXA from a “hold” rating to a “sell” rating in a research note on Thursday, March 24th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on AXA from €29.50 ($32.07) to €29.00 ($31.52) and set a “buy” rating on the stock in a research note on Wednesday, March 16th. One equities research analyst has rated the stock with a sell rating, one has issued a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, AXA presently has a consensus rating of “Buy” and a consensus price target of $32.00.
AXAHY opened at $29.14 on Monday. AXA has a 12-month low of $23.62 and a 12-month high of $33.20. The company has a debt-to-equity ratio of 0.15, a quick ratio of 0.10 and a current ratio of 0.10. The stock has a fifty day moving average of $28.61 and a 200-day moving average of $29.14.
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through France, Europe, Asia, AXA XL, International, and Transversal & Central Holdings segments. It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products.
- Get a free copy of the StockNews.com research report on AXA (AXAHY)
- Levi Straus Stock Ready to Buy the Dip
- Bed Bath & Beyond Stock Ready to Scale Into
- Institutions And Analysts Drive UnitedHealth Group Higher
- MarketBeat: Week in Review 4/11 – 4/15
- Three Beaten Down Mega Caps The Analysts Are Upgrading
Receive News & Ratings for AXA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AXA and related companies with MarketBeat.com's FREE daily email newsletter.